Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-10-08

Clinical Trial Update: A Placebo-Controlled Trial of Memantine for Alcohol Dependence [Phase 2]

View source ↗

Summary

A placebo-controlled Phase 2 trial of memantine for alcohol dependence has completed, sponsored by the NIAAA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Namenda (memantine)

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcohol Dependence (Primary Condition), Alcohol Abuse | Phase 2 | Status: COMPLETED